Title : XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB.

Pub. Date : 2018 Dec

PMID : 30510142






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Furthermore, downregulation of the NFkappaB gene signature, as opposed to BCR signature, was a common feature that underlies the response of MCL to both selinexor and ibrutinib. ibrutinib nuclear factor kappa B subunit 1 Homo sapiens
2 Meanwhile, unaltered NFkappaB was associated with ibrutinib resistance. ibrutinib nuclear factor kappa B subunit 1 Homo sapiens
3 Our data highlight the role of NFkappaB pathway in drug response to ibrutinib and selinexor and show the potential of using selinexor to prevent and overcome intrinsic ibrutinib resistance through NFkappaB inhibition. ibrutinib nuclear factor kappa B subunit 1 Homo sapiens